Exit this survey

Thank you for attending the Targeting DNA Methylation and Chromatin for Cancer Therapy Conference. The AACR is accredited by the ACCME to provide continuing medical education for physicians. The AACR designates this live activity for a maximum of 17.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Request for Credit
To receive CME Credit you must complete the following Request for Credit Survey. A credit certificate (for physicians) or certificate of attendance (for non physician attendees) will only be issued to those who complete the survey. Your certificate will be sent by email after the survey is completed.

Question Title

* 1. Contact Information

Question Title

* 2. Please enter your AACR ID number (If you don't have one, please leave blank)

Question Title

* 3. Address Information

Question Title

* 4. Please indicate your email address

APPROVED SESSIONS WORKSHEET PDF: If you don't remember which sessions you attended, please access the following link to the Sessions Worksheet PDF: Targeting DNA Methylation and Chromatin CME Sessions Worksheet

Question Title

* 5. Number of Credits Claimed

Question Title

* 6. Select One

Question Title

* 7. Which statement best describes your practice setting?

Question Title

* 8. Please rate your scope of knowledge in Targeting DNA Methylation and Chromatin for Cancer Therapy prior to participating in this CME activity.

  Little Knowledge Some Knowledge Moderate Knowledge Above Average Knowledge Extensive Knowledge
Knowledge Level

Question Title

* 9. Activity included opportunity to learn interactively from faculty/participants?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

Question Title

* 10. Content covered was useful and relevant to my practice?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

Question Title

* 11. To what extent were the learning objectives met by this CME activity?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Explain current research on environment, inflammation, and DNA repair.
Provide examples of epigenetic modulation in the development of cancer.
Identify examples of DNA methylation and chromatin cross-talk and their role in cancer.
Assess the role of noncoding genome in cancer.
Articulate how DNA methylation is being and can be targeted in the clinic.

Question Title

* 12. The speakers presented sufficient scientific evidence to support the content presented?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

Question Title

* 13. Meeting presentations were free from commercial influence or bias?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

Question Title

* 14. Please rate how likely you are to make changes in your practice in the following areas:

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Incorporate new knowledge of the contributions of laboratory research to drug development and patient care, as well as the epidemiological implications of cancer incidence and mortality.
Incorporate critical concepts, related skills, and/or methods associated with basic cancer research into the clinical practice of oncology to aid in the detection, diagnosis, treatment, and prevention of cancer.
Refine clinical research design and protocols that improve patient outcomes.
Develop new interdisciplinary collaborations to advance the progress of cancer research from “bench to bedside and back” yielding further improvements in patient outcomes.

Question Title

* 15. As a result of your participation in the Targeting DNA Methylation and Chromatin for Cancer Therapy Conference, what are you going to do differently? Please indicate any changes to your practice:

Question Title

* 16. Please indicate any barriers you perceive in implementing changes to your practice (check all that apply).

Question Title

* 17. Please rate your scope of knowledge in Targeting DNA Methylation and Chromatin for Cancer Therapy after participating in this CME activity.

  Little Knowledge Some Knowledge Moderate Knowledge Above Average Knowledge Extensive Knowledge
Knowledge Level

Question Title

* 18. Please provide any additional comments or suggestions for use in planning future AACR CME activities.

Thank you for your participation in the Targeting DNA Methylation and Chromatin for Cancer Therapy Conference. Your certificate will be processed soon and sent by email.
( Privacy & Cookie Notice

T